A data analysis published in a scientific journal indicates that differences with placebo are marginal for most treatments ...
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...
22h
News Medical on MSNOnly around 1 in 10 common non-surgical and non-invasive treatments for back pain are effective, analysis suggestsOnly around one in 10 common non-surgical and non-invasive treatments for lower back pain are effective, suggests a pooled ...
Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...
Kennedy Jr., the new head of the Department of Health and Human Services, has suggested that vitamin A supplements are just ...
1d
MarketBeat on MSNIs Viking Therapeutics the Next Blockbuster GLP-1 Stock?Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.
Nobody complains that we have more cancer medicines available today than in the 1980s. Why should we complain about having ...
They found that just one treatment for acute low back pain and five treatments for chronic – or long-term – back pain were ...
6d
MedPage Today on MSNRapid Improvement in Atopic Dermatitis With Dual JAK/TYK2 InhibitorORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...
Incyte Corporation (NASDAQ:INCY) released topline results from its pivotal Phase 3 STOP-HS clinical trial program of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results